GlassScriptPhysician profile
Michael P Hemphill
NPI 1104017482
$3,177.80
in general payments reported to CMS, 2019-2025
20 companies · $411 in 2025
The $411 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $71.73 · 2021: $179 · 2022: $243 · 2023: $337 · 2024: $1,696 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374 · Travel and Lodging: $1,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.78 |
| Travel and Lodging | $1,069.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $1,119.17 | 2024 | |
| Mayne Pharma Commercial LLC | $428.12 | 2023-2025 | |
| Exact Sciences Corporation | $294.32 | 2023-2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $272.78 | 2019-2022 | |
| Pfizer INC. | $192.54 | 2020-2024 | |
| Celgene Corporation | $154.27 | 2019-2020 | |
| Minerva Surgical, INC | $131.10 | 2019-2025 | |
| Organon LLC | $112.15 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $98.43 | 2024-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $62.29 | 2023-2025 | |
| Davol INC. | $52.82 | 2024 | Arista Ah Flexitip |
| Abbvie INC. | $49.00 | 2021-2023 | |
| Exeltis, USA INC. | $48.38 | 2023-2025 | Slynd |
| Emd Serono, INC. | $38.88 | 2019 | |
| Coopersurgical, INC. | $31.33 | 2025 | Paragard T 380a |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $22.63 | 2019 | |
| Daiichi Sankyo INC. | $20.20 | 2024 | Injectafer |
| Roche Diagnostics Corporation | $19.70 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.24 | 2020 | |
| Avion Pharmaceuticals | $14.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hemphill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.